A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum
NCT02318914 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2016-04-27
Summary
The study will evaluate the long-term safety of gevokizumab in treating active PG ulcers
Conditions
- Pyoderma Gangrenosum
Interventions
- DRUG
-
gevokizumab
Sponsors & Collaborators
-
XOMA (US) LLC
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2016-02-29
- Completion
- 2016-02-29
Countries
- United States
- Australia
- Canada
Study Locations
More Related Trials
-
A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris
NCT02704429 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum
NCT05964413 ·Status: TERMINATED ·Phase: PHASE3
-
Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
NCT07113743 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
NCT06325709 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.
NCT06663943 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children
NCT00927134 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum
NCT04274166 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT03628924 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum
NCT00730717 ·Status: WITHDRAWN ·Phase: PHASE2
-
Gene Therapy for Chronic Granulomatous Disease
NCT00394316 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers
NCT04186559 ·Status: UNKNOWN ·Phase: PHASE2
-
Gene Therapy for Chronic Granulomatous Disease
NCT00564759 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids
NCT03616184 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Adverse Events and Change in Disease State in Adult Participants Being Treated With Humira in Participants Diagnosed With Pyoderma Gangrenosum (PG)
NCT04750213 ·Status: COMPLETED
-
Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease
NCT02234934 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Use of Infliximab for the Treatment of Pemphigus Vulgaris
NCT00283712 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects
NCT02365948 ·Status: COMPLETED ·Phase: PHASE1
-
Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease
NCT06876363 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study
NCT05192200 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris
NCT04023149 ·Status: UNKNOWN ·Phase: PHASE2
-
Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
NCT02613910 ·Status: TERMINATED ·Phase: PHASE3
-
Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum
NCT03971643 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
NCT05263934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
NCT05681481 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum
NCT05569252 ·Status: COMPLETED ·Phase: PHASE2